Company Name:Cellectis S.A.
CEO: Andre Choulika

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: Cellectis SA is a gene-editing company, employing its core proprietary technologies to develop products in the emerging field of immuno-oncology. Its two segment includes Therapeutics and Plants.


Key numbers

Market Capitalization:574290321
Shares Outstanding: 42445700
Float: 42145311.7811
Next Earning Date:2020-03-16
TTm EPS: -2.0634
TTm Dividend Rate:
200 days moving average:15.37
50 days moving average: 11.43
One day percent Change: 1.81



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,